Generic Medicine Info
Should be taken with food.
Severe or moderate renal impairment. Patients with uric acid renal calculi, urinary uric acid excretion rates >700 mg/24 hr.
Special Precautions
May exacerbate and prolong acute gout; start treatment only after acute attack has subsided. Adequate fluid intake should be maintained. Monitor liver function.
Adverse Reactions
GI effects; acute attack of gout, uric acid renal calculi, renal colic. May cause liver damage.
Drug Interactions
Efficacy may be antagonised when used with aspirin and other salicylates. May increase the activity of coumarin oral anticoagulants.
ATC Classification
M04AB03 - benzbromarone ; Belongs to the class of preparations increasing uric acid excretion. Used in the treatment of gout.
Disclaimer: This information is independently developed by CIMS based on benzbromarone from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in